Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech

View source ↗

Summary

Mayo Clinic is conducting a study on the neurobiology of two distinct types of progressive apraxia of speech, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Apraxia of Speech, Non-fluent Aphasia | Status: RECRUITING